Menu
Menu
Menu
B. Pharm (University of the Punjab, Pakistan),
M. Phil Pharmacology & Toxicology (UVAS, Pakistan),
PhD (University of Muenster, Germany)
Tel: +92-42-99214341
Mobile: +92-333-4548265
Email: usman.ips@uvas.edu.pk
Dr. Muhammad Usman, is Assistant Professor at Institute of Pharmaceutical Sciences (IPS), University of Veterinary & Animal Sciences, Lahore, Pakistan. He got B.Pharmacy degree from University of the Punjab in 2005 and M.Phil in Pharmacology and Toxicology from University of Veterinary and Animal Sciences, Lahore in 2008. He went to Germany in 2013 and completed his doctoral degree in December 2016 from University of Muenster, Germany.
He started his professional career in Feb 2006 as Community Pharmacist and served at Himont Pharmacy Gujranwala as Branch Manager for 9 months. Then he joined Doctor’s Hospital and Medical Centre as retail Pharmacist on 02-11-2006 and worked till 07-11-2008.
Immediately after completion of his M.Phil in 2008 he joined Institute of Pharmaceutical Sciences, UVAS as Lecturer on 08-11-2008 and was a member of pioneer team in the establishment of this esteemed Institute.
He is also a part of Bioequivalence Study Center (BeSt Center), UVAS, Lahore. He is skillful in conducting clinical trials for Bioequivalence studies and quantification of drugs in biological fluids through HPLC.
The research title of his M.Phil Thesis was “Comparative pharmacokinetics of Levofloxacin in Healthy Volunteers and in Patients Suffering from Typhoid Fever”. During M.Phil he got hands on training of clinical trials and quantification of drug concentrations in human plasma by using HPLC.
The area of research in Doctoral study is Population Pharmacokinetics in Elderly Patients. He got a good experience of working on different Pharmacokinetic software including NONMEM® and PK-Sim®. He is the Pioneer Pharmacometrician who is introducing this technique in Pakistan and has developed Pakistan’s 1st ever Pharmacometrics Laboratory at IPS, UVAS.
Dr. Muhammad Usman is representing Pakistan in Asian Pharmacometrics Network (APN) as Board member. He has also represented Pakistan as Pharmacometrician at different scientific forums in Pakistan and across the globe.
|
As Principal Investigator |
|||
|
Title |
Funding agency | Amount | Status |
| Population Pharmacokinetics of Vancomycin in Pakistani Patients. | Higher Education Commission of Pakistan
under Start Up Research Grant (SRGP) Program |
PKR
0.5 Million |
Completed |
| Population Pharmacokinetics of Antibiotics in Pakistani Patients. | Higher Education Commission of Pakistan
Under National Research Program for Universities (NRPU) |
PKR
1.983 Million |
Completed |
|
As Co-Principal Investigator |
|||
| In-silico exploration of 6‑Substituted 2‑Arylaminopurines selectivity for CDK2 and CDK1 through Linear Interaction energy (LIE) and molecular dynamics simulations | Higher Education Commission of Pakistan
under Start Up Research Grant (SRGP) Program |
PKR
0.5 Million |
Completed |
| Development of stem cell therapy for treating cutaneous wounds in canines: a translational model for humans |
Higher Education Commission of Pakistan
Under National Research Program for Universities (NRPU) |
6.135 Million | On Going |
| Determination of N-Nitroso dimethyl amine in amine-based anti-hypertensive drugs and their association with cancer | Higher Education Commission of Pakistan
Under National Research Program for Universities (NRPU) |
5.096 Million | On Going |
Board member of Asian Pharmacometrics Network (APN) as representative of Pakistan
|
Student’s name |
Thesis title |
Status |
| Muhammad Ahmad Aaqib
(2017-VA-45) |
Formulation development and evaluation of gastro-resistant tablet of ifosfamide using beta-cyclodextrin and hydroxylpropyl methylcellulose | Completed
(2019) |
| Muhammad Muaaz Munir
(2011-VA-729) |
Population pharmacokinetics of vancomycin in Pakistani patients | Completed
(2019) |
| Muhammad Noman Akram
(2011-VA-731) |
Therapeutic drug monitoring of vancomycin through validated HPLC method | Completed
(2020) |
| Ammara Arif
(2012-VA-732) |
Population pharmacokinetics of moxifloxacin in Pakistani patients | Completed
(2020) |
| Syeda Zia-ul-Ain Bukhari
(2018-VA-65) |
Simultaneous quantification of moxifloxacin and linezolid in human plasma using HPLC | Completed
(2020) |
| Asim Ali
(2011-VA-728) |
Formulation development and in-vitro characterization of solid dispersion tablets of carbamazepine for enhancing bioavailability | Completed
(2021) |
| Syed Ehsan ul Haq
(2019-mphil-1176) |
Population pharmacokinetics of Vancomycin in elderly patients from pooled clinical data | Completed
(2021) |
| Faiza Urooj
(2019-mphil-1179) |
Risk based prioritization of essential antimicrobial agents based on BCS classification and review of bioanalytical methods for mandatory bioequivalence status | Completed
(2021) |
| Hammad Ahmad
(2019-mphil-1205) |
A comparative study on non-prescription dispensing of antibiotics and narcotics at drug sale outlets in urban areas of Lahore | Completed
(2021) |
| Annum Maha
(2019-mphil-2141) |
Population Pharmacokinetics of linezolid in Pakistani Patients | Completed
(2022) |
| Akasha Jamshaid
(2015-VA-294) |
Impact of pharmacist's interventions in ensuring therapeutic outcomes of anti-tuberculosis drugs in TB patients with comorbidities in a public sector health facility | Completed
(2022) |
| As Co-Supervisor | ||
| Student’s name | Thesis title | Status |
| Rabia Saleem
(17-M/LCWU-16) |
Population pharmacokinetics of ciprofloxacin among indoor patients of tertiary care hospitals, Lahore, Pakistan
|
Completed
(2020) |
| Madiha Zaman
(17-M/LCWU-11) |
population pharmacokinetics of meropenem among post-operative patients
|
Completed
(2020) |
| Qurrat-ul-Ain Yousaf
(17-M/LCWU-14) |
Comparative population pharmacokinetics of valproic acid in Pakistani patients and Korean patients
|
Completed
(2020) |
| Sitaram Khadka
15-MCol-M19a
|
Comparative pharmacokinetics of meropenem in young and elderly patients through a non-linear mixed effect modelling approach | Completed
(2022) |
|
As Member of Supervisory Committee |
||
|
Student’s name |
Thesis title |
Status |
| Muhammad Shahwar
(2009-VA-017) |
Evaluation of Good Pharmacy Practice in
Community Drug Sale outlets with "A" Category License in the Urban Lahore. |
Completed
(2011) |
| Asad Ali Lodhi
2009-VA-343 |
Study for detection, evaluation, and strategies to minimize medication errors in tertiary care teaching hospitals Lahore | Completed
(2019) |
| Rehan Ali
2009-VA-343 |
Comparison of in-vitro drug release of different brands of Co-amoxiclave using HPLC method | Completed
(2019) |
| Qurrat-ul-Ain Khan
2017-VA-98 |
Development and characterization of orodispersible film containing cefixime trihydrate as a model drug | Completed
(2019) |
| Sadaf Aroosa
2017-Mphil-1591 |
Impact of dexmedetomidine infusion on isoflurane induced oxidative stress and DNA damage in patients undergoing major emergency surgery | Completed
(2019) |
| Iffat Akhtar
2013-VA-291 |
Investigation of efficacy of complementary and alternative medicine for peripheral arterial disease: A systematic review and meta-analysis | Completed
(2021) |
| Yasmeen Iqbal
2019-mphil-1182 |
Population Pharmacokinetics of meropenem in adult patients from pooled clinical data | Completed
(2021) |
| Zunair Maqsood
2019-mphil-1185 |
Challenges and Opportunities in sustainability of Bioequivalence Study Centers in Pakistan | Completed |
| Asma Rabail
2019-mphil-1188 |
Formulation of Doxorubicin loaded PLGA Nanoparticles for gastric cancer using Thiolated Hydroxy Ethyl Cellulose | Completed
(2021) |
| Muhammad Bilal Saeed
2020-VA-308 |
Impact of interventions by ward pharmacist in tertiary care teaching hospital on medication use pattern and safety using action research
|
On Going |
| Umaira Israr
2020-VA-1484 |
Prices, availability, and affordability study of essential antifungal, antiviral and antiparasitic medicines in Lahore, Pakistan using WHO/HAI Methodology
|
Completed
(2022) |
| Nawal Nida
2014-VA-158 |
Analysis of drug-drug interactions in outpatient department of charity based hospital | Completed
(2022) |
| Muhammad Chaudhry
2014-VA-137 |
Formulation of thiolated mucoadhesive intravesical nanpoparticles for bladder cancer | Completed
(2022) |
Developed Pakistan’s first Pharmacometrics lab for carrying out research on Population Pharmacokinetic (popPK) modelling, Pharmacokinetic Pharmacodynamic (PKPD) modelling and Physiologically Based Pharmacokinetic (PBPK) modelling.
|
Sr. No. |
Course No. |
Course Title |
Class |
Credit Hours |
|
1 |
PHCU 1021 |
Population pharmacokinetic Modelling |
M.Phil (Pharmaceutics) |
3(2-1) |
For further queries, feel free to contact
© Designed and Maintained by Information Technology Center
